Graffinity Pharmaceuticals Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Graffinity Pharmaceuticals General Information

Description

Developer of artificial intelligence-powered educational software designed for student learning assessment and knowledge visualization. The company's platform provides artificial intelligence-supported knowledge mapping, formative assessment capabilities, learning analytics, visualization of student thinking processes, and progress tracking features, enabling educators and academic institutions to evaluate understanding, identify knowledge gaps, monitor learning development, and support instructional planning.

Contact Information

Formerly Known As
Graffinity
Ownership Status
Acquired/Merged
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Heidelberg
  • Germany
Primary Industry
Drug Discovery
Other Industries
Vertical Market Software
Educational Software
Acquirer
Corporate Office
  • Heidelberg
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Graffinity Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Startup
2. Merger/Acquisition 18-Nov-2010 Completed Startup
1. Merger/Acquisition 03-Jan-2006 Completed Startup
To view Graffinity Pharmaceuticals’s complete valuation and funding history, request access »

Graffinity Pharmaceuticals Patents

Graffinity Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014020152-A1 Ligands for apheresis and immunoabsorption Inactive 02-Aug-2012
WO-2013117707-A1 Ligands for antibody and fc-fusion protein purification by affinity chromotography iv Inactive 08-Feb-2012
WO-2012020080-A3 Ligands for affinity chromatography Inactive 12-Aug-2010
WO-2012020080-A2 Ligands for antibody and fc-fusion protein purification by affinity chromatography ii Inactive 12-Aug-2010
WO-2012017021-A2 Ligands for antibody and fc-fusion protein purification by affinity chromatography Inactive 03-Aug-2010 C07K1/22
To view Graffinity Pharmaceuticals’s complete patent history, request access »

Graffinity Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Graffinity Pharmaceuticals FAQs

  • When was Graffinity Pharmaceuticals founded?

    Graffinity Pharmaceuticals was founded in 1998.

  • Where is Graffinity Pharmaceuticals headquartered?

    Graffinity Pharmaceuticals is headquartered in Heidelberg, Germany.

  • What is the size of Graffinity Pharmaceuticals?

    Graffinity Pharmaceuticals has 20 total employees.

  • What industry is Graffinity Pharmaceuticals in?

    Graffinity Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Graffinity Pharmaceuticals a private or public company?

    Graffinity Pharmaceuticals is a Private company.

  • What is Graffinity Pharmaceuticals’s current revenue?

    The current revenue for Graffinity Pharmaceuticals is .

  • Who acquired Graffinity Pharmaceuticals?

    Graffinity Pharmaceuticals was acquired by NovAliX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process